The letter
Copy it into your prescriber’s letterhead. Everything in brackets is a blank to fill or delete.
[Prescriber name, credentials] [Practice name] [Address] · [Phone] · [Fax] NPI: [number] [Date] To: [Health plan or pharmacy benefit manager], Prior Authorization Department Fax: [plan's prior authorization fax] Re: Prior authorization request for Wegovy (semaglutide) [injection / tablets], [dose] Patient: [full name] · Date of birth: [DOB] Member ID: [ID] · Group: [group number] I am writing to request coverage of Wegovy for my patient, [full name], for chronic weight management. Wegovy is FDA-approved, in combination with a reduced calorie diet and increased physical activity, to reduce excess body weight and maintain weight reduction long term in adults with obesity, and in adults with overweight in the presence of at least one weight-related comorbid condition. Clinical summary - Current weight [weight] and height [height] on [date]; BMI [BMI] kg/m2. - Baseline BMI before any weight-loss medication: [BMI] on [date]. - Weight-related conditions: [condition, ICD-10 code, date diagnosed]; [condition, ICD-10 code, date diagnosed]. - Weight-management program: [program or approach], from [start date] to [end date], including a reduced-calorie diet, increased physical activity and [behavioral counseling], documented in notes dated [dates]. Weight change during the program: [change]. - Previous weight-loss medications: [drug, dates, outcome or reason stopped], or none. - I have reviewed the prescribing information, including contraindications and warnings, with the patient: [relevant notes]. Request Please approve Wegovy [dose and form], [quantity] per [days supply], for [the initial approval period your policy allows]. Wegovy will be used together with the reduced-calorie diet and increased physical activity described above. If another product is required first: the patient tried [drug] from [date] to [date] and stopped because of [reason], or cannot take it because [reason]. [Delete this paragraph if not needed.] The patient meets your published criteria for this request: [restate the plan's own criteria and point to where each is documented in the enclosed notes]. Enclosed: chart notes documenting height, weight and BMI with dates; records of the weight-management program; medication history. Please contact my office at [phone] with any questions or if further documentation is needed. Sincerely, [Prescriber signature] [Prescriber name, credentials]
If the request is for cardiovascular risk reduction
WEGOVY is also indicated to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either obesity or overweight. [Patient] has established cardiovascular disease: [prior myocardial infarction / prior stroke / peripheral arterial disease], documented on [date].
The FDA-approved use, word for word
The letter’s first paragraph restates this, so the request and the label say the same thing.
1“WEGOVY injection is indicated in combination with a reduced calorie diet and increased physical activity: … to reduce excess body weight and maintain weight reduction long term in: o adults and pediatric patients aged 12 years and older with obesity. o adults with overweight in the presence of at least one weight-related comorbid condition.”
DailyMed, Wegovy prescribing information · effective 2026-06-18





